131 related articles for article (PubMed ID: 10534908)
1. Surgical complications in hematological malignancies.
Nenova I; Grudeva-Popova J; Dimov R; Chapkunov A; Mihailov H
Folia Med (Plovdiv); 1999; 41(2):16-21. PubMed ID: 10534908
[TBL] [Abstract][Full Text] [Related]
2. Mucocutaneous infections in hematological malignancies.
Grudeva-Popova J; Goranov S
Folia Med (Plovdiv); 1999; 41(3):40-4. PubMed ID: 10658365
[TBL] [Abstract][Full Text] [Related]
3. Selective surgical indication in the management of neutropenic children presenting with acute abdomen.
Sbragia Neto L; Oliveira-Filho AG; Epelman S; Koeller HF; Bustorff-Silva JM; Brandalise SR
Pediatr Hematol Oncol; 2000 Sep; 17(6):483-7. PubMed ID: 10989469
[TBL] [Abstract][Full Text] [Related]
4. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
[TBL] [Abstract][Full Text] [Related]
5. Hematologic malignancies and thrombosis.
Elice F; Rodeghiero F
Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
[TBL] [Abstract][Full Text] [Related]
6. Disparities in the risk of septic events in patients undergoing splenectomy for hematological malignancies (D-ROSE-PUSH): A study based on ACS-NSQIP database.
Saliba AN; Tamim H; Mailhac A; Jamali FR; Taher AT
Am J Hematol; 2019 Aug; 94(8):E205-E207. PubMed ID: 31034629
[No Abstract] [Full Text] [Related]
7. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies.
Tam CS; Galanos J; Seymour JF; Pitman AG; Stark RJ; Prince HM
Am J Hematol; 2004 Sep; 77(1):72-6. PubMed ID: 15307110
[TBL] [Abstract][Full Text] [Related]
8. Human plasma cell-free DNA as a predictor of infectious complications of neutropenic fever in hematological patients.
Purhonen AK; Juutilainen A; Vänskä M; Lehtikangas M; Lakkisto P; Hämäläinen S; Koivula I; Jantunen E; Pulkki K
Infect Dis (Lond); 2015 Apr; 47(4):255-9. PubMed ID: 25664374
[TBL] [Abstract][Full Text] [Related]
9. Infections of febrile neutropenic patients in malignant hematological diseases.
Rókusz L; Liptay L
Mil Med; 2003 May; 168(5):355-9. PubMed ID: 12775168
[TBL] [Abstract][Full Text] [Related]
10. Liver resection for hepatocellular carcinoma in patients with hematological malignancies.
Lin HC; Yang YS; Teng CJ; Shen CH; Jan YG; Cheng SB; Wu CC; Lin YL; Huang CC; P'eng FK
World J Surg Oncol; 2017 Nov; 15(1):194. PubMed ID: 29096656
[TBL] [Abstract][Full Text] [Related]
11. Footwear exchange has no influence on the incidence of febrile neutropenia in patients undergoing chemotherapy for hematologic malignancies.
Sugahara H; Mizuki M; Matsumae S; Nabetani Y; Kikuchi M; Kanakura Y
Infect Control Hosp Epidemiol; 2004 Jan; 25(1):51-4. PubMed ID: 14756220
[TBL] [Abstract][Full Text] [Related]
12. [Traceability of oncohematological drugs through data capture codes].
Escudero-Vilaplana B; Manso-Manrique M; García-Sanz E; Sánchez-Guerrero A
Farm Hosp; 2017 Sep; 41(5):649-650. PubMed ID: 28847260
[No Abstract] [Full Text] [Related]
13. [Protocol for the Prevention of Infections Related to the Treatment of Hematological Malignancies].
Silva-Pinto A; Rocha-Pereira N; Andrade J; Sarmento A; Santos L
Acta Med Port; 2018 Jun; 31(6):347-361. PubMed ID: 30020882
[TBL] [Abstract][Full Text] [Related]
14. Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.
Miyahara T; Mochinaga S; Kimura S; Aragane N; Yakabe T; Morita S; Okudaira K; Fujito H
Cancer Chemother Pharmacol; 2013 Jan; 71(1):175-82. PubMed ID: 23064956
[TBL] [Abstract][Full Text] [Related]
15. Management of hematological malignancies in patients affected by renal failure.
Niscola P; Vischini G; Tendas A; Scaramucci L; Giovannini M; Bondanini F; Romani C; Brunetti GA; Cartoni C; Cupelli L; Ferrannini M; Perrotti A; Del Poeta G; Palumbo R; de Fabritiis P
Expert Rev Anticancer Ther; 2011 Mar; 11(3):415-32. PubMed ID: 21417855
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of invasive pulmonary fungal infection in hematology patients.
Theodore S; Liava'a M; Antippa P; Wynne R; Grigg A; Slavin M; Tatoulis J
Ann Thorac Surg; 2009 May; 87(5):1532-8. PubMed ID: 19379899
[TBL] [Abstract][Full Text] [Related]
17. Stem cell transplantation using non-myeloablative conditioning regimen with fludarabine for hematological malignancies.
Tajika K; Yamaguchi H; Mizuki T; Nakamura H; Nakayama K; Dan K
J Nippon Med Sch; 2010 Oct; 77(5):254-9. PubMed ID: 21060236
[TBL] [Abstract][Full Text] [Related]
18. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
19. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
20. Management of hematological patients requiring emergency chemotherapy in the intensive care unit.
Lafarge A; Chean D; Whiting L; Clere-Jehl R; ;
Intensive Care Med; 2024 Jun; 50(6):849-860. PubMed ID: 38748265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
